QuidelOrtho Corp·4

Jun 9, 4:06 PM ET

POLAN MARY LAKE PH D 4

4 · QuidelOrtho Corp · Filed Jun 9, 2026

Research Summary

AI-generated summary of this filing

Updated

QuidelOrtho (QDEL) Director Mary Lake Polan Receives 973 Shares

What Happened

  • Mary Lake Polan, Ph.D., a non-employee director of QuidelOrtho Corporation (QDEL), had restricted stock units (RSUs) released and converted into 973 shares of common stock (749 + 224) on 2026-06-06. The shares were recorded at $0.00 per share (no cash paid or received in the filing), reflecting settlement of previously granted RSUs rather than an open-market purchase or sale.

Key Details

  • Transaction date(s): 2026-06-06; Form 4 filed: 2026-06-09.
  • Items reported: Two RSU releases/awards (A) for 749 and 224 shares; corresponding derivative conversions/exercises (M) for the same amounts. Price reported: $0.00 per share.
  • Total shares involved: 973 shares. No cash value reported on the form (shares issued upon RSU settlement).
  • Shares owned after transaction: Not specified in the provided filing details.
  • Footnotes: (F1) Release of RSUs previously reported on a Form 4; (F2) each RSU = one share; (F3) release was deferred under QuidelOrtho’s deferred compensation program for participating non-employee directors and occurred per the elected deferral schedule.
  • Filing timeliness: Form 4 was filed three days after the transaction date (06-09 reporting transactions dated 06-06). The filing shows no explicit late-filing flag.

Context

  • This was an RSU settlement/conversion event, not a market sale or purchase. The $0.00 reporting reflects internal conversion/settlement mechanics (no purchase price or cash sale).
  • Such deferred-RSU releases for non-employee directors are routine compensation events and do not necessarily reflect the director’s buy/sell sentiment.

Insider Transaction Report

Form 4
Period: 2026-06-06
Transactions
  • Award

    Common Stock

    [F1]
    2026-06-06+74920,218 total
  • Award

    Common Stock

    [F1]
    2026-06-06+22420,442 total
  • Exercise/Conversion

    Restricted Stock Units (Converted)

    [F2][F3]
    2026-06-067490 total
    Common Stock (749 underlying)
  • Exercise/Conversion

    Restricted Stock Units (Premium)

    [F2][F3]
    2026-06-062240 total
    Common Stock (224 underlying)
Holdings
  • Common Stock

    (indirect: By LLC)
    17,353
Footnotes (3)
  • [F1]Reflects release of restricted stock units that were previously reported on a Form 4.
  • [F2]Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • [F3]Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.
Signature
/s/ Phillip S. Askim, attorney-in-fact for Mary Lake Polan, Ph.D.|2026-06-09

Documents

1 file
  • 4
    wk-form4_1781035597.xmlPrimary

    FORM 4